Please login to the form below
Case Study
This page shows the latest Case Study news and features for those working in and with pharma, biotech and healthcare.
Moderna’s COVID-19 vaccine offers high levels of protection for adolescents
The study results showed a vaccine efficacy of 100% starting 14 days after the second dose. ... Moderna added that since the incidence rate of COVID-19 is lower in this age group, the study also evaluated a secondary case definition based on the CDC
Latest news
-
US Department of Health and Human Services calls for coronavirus product proposals
On the therapeutics front, the NIH has already initiated testing of Gilead’s anti-viral drug remdesivir in a phase 1 study in the US. ... Participants in the study must have a laboratory-confirmed case of the novel coronavirus as well as evidence of
-
Raising awareness and encouraging support on Rare Disease Day 2020
One personal account for Rare Disease Day is a case study in which Dimitri Azzopardi explains what it is like to live with beta thalasseamia, a debilitating, life-long genetic blood
-
J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data
However, remissions in the study last on average for 10.6 months, and median progression-free survival was 8.6 months. ... The KarMMa study also had a case of patient death due to cytokine release syndrome as a side-effect of treatment with ide-cel
-
Amgen, Servier heart failure drug clears trial hurdle
Amgen and Servier have inched closer to a verdict on their first-in-class chronic heart failure drug omecamtiv mecarbil, after their first phase 3 study passed a futility review. ... In the case of the GALACTIC-HF study of omecamtiv, the interim
-
Safety first: AI adoption in the healthcare sector
The Royal Free London NHS Foundation Trust’s 2015 partnership with DeepMind is a case study of what can go wrong, despite the very best of intentions. ... Exit: provide for knowledge transfer services and exit support in the case of an unforeseen
More from news
Approximately 0 fully matching, plus 117 partially matching documents found.
Latest Intelligence
-
Mapping patient pathways with a focus on patient-centricity: the role of medical education
Diabetes: as a case study for patient-centricity. For patients with diabetes, many HCPs are involved in planning patient management, with the patient at the heart of any decisions.
-
Well-funded life sciences firms are making long-term progress – and their investors are too
Without the catalyst that COVID-19 has turned out to be, alongside easier access to investment, this arguably would not otherwise have been the case. ... challenge study, in this case respiratory syncytial virus (RSV).
-
Case-study for thalassaemia: Dimitri Azzopardi
An in-depth look at beta thalassaemia for Rare Disease Day
-
Case study: See Below
- - PMLiVE - PMLiVE
-
Case study: Project Family
Highlights included:. Safe birth: Making the publication of the findings of the CHAMPION study, an initiative that Ferring has worked on with the World Health Organization and others, a truly global ... The study showed the effect Ferring’s treatment
More from intelligence
Approximately 3 fully matching, plus 92 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
mind. Case study: redesigning the pelvic floor trainer. Elvie first entered the market with a pelvic floor trainer. ... If this is to be the case, a key consideration will be that while the primary audience for femtech right now is of an age more likely
-
Reflections on the MAPS EMEA 2022 Annual Meeting
BioNTech’s Project Lightspeed is a case study in this – setting the highest standard to accelerate the development and commercialization of a COVID-19 vaccine in record time.
-
Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events
support. Read the full case study here (no download required!).
-
Increasing patient randomisation rate by 200% for a Top 5 global pharma
Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study. A Top 5 pharma was looking to randomise 192 patients with moderate to severe HS at 60 sites across the USA, Canada
-
Committing time to making meaningful connections - top 5 tips
Still in need of inspiration? Check out this excellent case study which shows how it’s possible to involve those often seen to be less engaged in science and research:.
More from PMHub
Approximately 23 fully matching, plus 86 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
